- ISIN
- US23306J1016
- CUSIP
- 23306J101
- Sector
- Healthcare
- Industry
- Biotechnology
- IPO Date
- Oct 22, 2014
Highlights
- Market Cap
- $1.52B
- Enterprise Value
- $1.31B
- EPS (TTM)
- -$1.89
- Gross Profit (TTM)
- -$8.90M
- EBITDA (TTM)
- -$159.48M
- Year Range
- $8.48 - $26.19
- Target Price
- $46.33
- ROA (TTM)
- -63.01%
- ROE (TTM)
- -80.74%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
DBVT Performance Chart
DBV Technologies S.A. (DBVT) is down 7.7% since the beginning of the year. At $18 per share, DBVT is trading 32.4% below its 52-week high of $26. Investors who bought $1,000 worth of DBVT shares 5 years ago would now be looking at an investment worth $320.
Loading charts...
Returns By Period
DBV Technologies S.A. (DBVT) has returned -7.67% so far this year and 122.92% over the past 12 months. Over the last ten years, DBVT has returned -25.38% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.
DBV Technologies S.A.
- 1D
- -2.91%
- 1M
- -9.09%
- YTD
- -7.67%
- 6M
- 36.26%
- 1Y
- 122.92%
- 3Y*
- -3.83%
- 5Y*
- -20.40%
- 10Y*
- -25.38%
Benchmark (S&P 500 Index)
- 1D
- -0.74%
- 1M
- 4.90%
- YTD
- 10.35%
- 6M
- 10.28%
- 1Y
- 26.52%
- 3Y*
- 20.83%
- 5Y*
- 12.30%
- 10Y*
- 13.66%
DBVT Monthly Returns History
Based on dividend-adjusted daily data since Oct 22, 2014, DBVT's average daily return is +0.05%, while the average monthly return is +0.67%. At this rate, an investment would double in approximately 8.7 years.
Historically, 43% of months were positive and 57% were negative. The best month was Jan 2021 with a return of +96.2%, while the worst month was Mar 2020 at -60.0%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 6 months.
On a daily basis, DBVT closed higher 45% of trading days. The best single day was Jun 9, 2022 with a return of +79.6%, while the worst single day was Dec 20, 2018 at -59.3%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 12.73% | -2.87% | -0.48% | 0.53% | -9.05% | -7.33% | -7.67% | ||||||
| 2025 | 36.73% | 5.33% | 53.26% | 32.11% | -7.33% | 9.70% | -7.10% | 13.40% | 3.63% | 46.40% | -10.59% | 46.45% | 520.39% |
| 2024 | -3.76% | -10.58% | -8.65% | -11.68% | -15.36% | -28.48% | 20.99% | -7.13% | -22.22% | 11.20% | 0.21% | -20.77% | -67.57% |
| 2023 | -13.73% | 9.85% | 16.55% | -11.83% | 30.87% | -2.56% | -22.11% | 6.76% | -13.92% | -25.74% | -26.73% | 28.76% | -37.73% |
| 2022 | -4.38% | -12.42% | 18.66% | -18.87% | 17.05% | 68.87% | -0.00% | -21.18% | -11.94% | -14.12% | -11.18% | 13.33% | -4.37% |
| 2021 | 96.18% | 4.09% | -0.37% | 22.51% | -10.41% | -6.67% | -4.76% | 13.85% | -17.23% | -38.16% | -0.99% | -46.67% | -38.93% |
Benchmark Metrics
DBV Technologies S.A. has an annualized alpha of 2.85%, beta of 0.68, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since October 23, 2014.
- This stock participated in 112.69% of S&P 500 Index downside but only -13.09% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.68 may look defensive, but with R2 of 0.02 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 2.85%
- Beta
- 0.68
- R²
- 0.02
- Upside Capture
- -13.09%
- Downside Capture
- 112.69%
Return for Risk
Risk / Return Rank
DBVT ranks 83 for risk / return — in the top 83% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for DBV Technologies S.A. (DBVT) and compare them to S&P 500 Index.
| DBVT | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.68 | ||
| Sortino ratioReturn per unit of downside risk | -0.49 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 1.41 | -0.12 |
| Calmar ratioReturn relative to maximum drawdown | 4.44 | 2.93 | +1.51 |
| Martin ratioReturn relative to average drawdown | 7.82 | 13.52 | -5.70 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the DBV Technologies S.A.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the DBV Technologies S.A. was 99.52%, occurring on Nov 22, 2024. The portfolio has not yet recovered.
The current DBV Technologies S.A. drawdown is 96.41%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2024 bear market2024 | -99.52%Nov 2024 | 7y 1mo | — | 8y 7moOct 2017 - now |
2016 bear market2016 | -48.12%Feb 2016 | 6mo 9d | 1y 5mo | 1y 12moAug 2015 - Jul 2017 |
2015 bear market2015 | -27.65%Mar 2015 | 4mo 20d | 3mo 15d | 8mo 5dOct 2014 - Jun 2015 |
2017 correction2017 | -14.19%Sep 2017 | 1mo 20d | 9d | 1mo 29dAug 2017 - Oct 2017 |
2017 pullback2017 | -2.80%Oct 2017 | 0s | 2d | 2dOct 2017 - Oct 2017 |
Drawdown Indicators
| DBVT | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.52% | -56.78% | -42.74% |
Max Drawdown (1Y)Largest decline over 1 year | -27.87% | -9.10% | -18.77% |
Max Drawdown (3Y)Largest decline over 3 years | -89.29% | -18.90% | -70.39% |
Max Drawdown (5Y)Largest decline over 5 years | -96.34% | -25.43% | -70.91% |
Max Drawdown (10Y)Largest decline over 10 years | -99.52% | -33.92% | -65.60% |
Current DrawdownCurrent decline from peak | -96.41% | -0.74% | -95.67% |
Average DrawdownAverage peak-to-trough decline | -70.27% | -10.72% | -59.55% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.77% | 1.97% | +13.80% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of DBV Technologies S.A. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how DBV Technologies S.A. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for DBVT in comparison with other companies in the Biotechnology industry. Currently, DBVT has a P/B value of 7.3. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with DBVT
Add DBV Technologies S.A. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with DBVT